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FIGURE 1. Preoperative and postoperative computed tomography scans of patients. Defect of
anterior wall of ascending aorta (dotted line); pseudoaneurysm arising from the right anterior wall
of ascending aorta (single arrow); repaired aorta with aortic valvular prosthetic replacement (double
arrow).
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ASCENDING AORTA
COMBINED WITH AORTIC
VALVE INFECTIVE
ENDOCARDITIS AFTER
CARDIAC OPERATIONS FOR
CONGENITALVENTRICULAR
SEPTAL DEFECT
To the Editor:
We read with great interest the arti-
cle of Emaminia and colleagues1 and
congratulate them for their successful
repair of an iatrogenic pseudoaneur-
ysm of the ascending aorta. Their strat-
egy to safely reopen the sternum is to
drain the blood into the oxygenator res-
ervoir for 1 to 2 minutes to have an
empty, relatively collapsed heart and
aortawithout establishment of femoro-
femoral bypass. Wewant to know how600 The Journal of Thoracic and Cmuch blood should be drained and how
to maintain hemodynamics during the
procedures. Fortunately, the pseudoa-
neurysm was located at the back of as-
cending aorta. Otherwise, how would
the hemodynamics problem be dealt
with if the reentry of the sternum was
not uneventful?
Ascending aortic pseudoaneurysms
are found on rare occasions, and direct
surgical repair is the only choice,
but this carries a high risk of fatal
hemorrhage resulting from rupture of
pseudoaneurysm at the time of sternal
reentry. From the limited case reports
in the literature,2-5 the authors
concluded that median sternotomy
with the use of femorofemoral bypass
and hypothermic circulatory arrest is
the strategy of choice.
We recently surgically managed
a case of ascending aortic pseudoa-
neurysm combined with aortic valve
infective endocarditis after congenital
ventricular septal defect. An 11-year-
old boy was admitted to our hospital
2 months later with intermittently
high fever accompanying stridor and
dizziness experienced for approxi-
mately 1 month. Echocardiography
showed masses in the prolapsed right
coronary cusp with severe aortic
regurgitation. Staphylococcus aureus
was cultured from the blood. A
contrast computed tomography scan
showed a defect in the right anteriorardiovascular Surgery c February 2011wall of the ascending aorta 1.5 cm
above the aortic valve, from which
a pseudoaneurysm was arising
(Figure 1). Intravenous antibiotics ac-
cording to in vitro susceptibility test-
ing were continued for 2 more
weeks, bacteremia was controlled,
and operation was performed. The
chest was opened through the previ-
ous scar. After institution of femorofe-
moral bypass, the patient was cooled
to 32C and the heart was relatively
emptied. A sternotomy was then per-
formed. Adhesions over the ascending
aortic pseudoaneurysm and right ven-
tricle were released uneventfully. The
aorta was clamped at 28C and
opened through the pseudoaneurysm,
which was approximately 8 3 7 3
5 cm. The 2.5 3 2.5-cm defect was
at the previous aortotomy site. Cardio-
plegic solution was administered
directly, and the aortic native valve
was replaced by a 21-mm St Jude me-
chanical prosthesis (St Jude Medical
Inc, St Paul, Minn). The aortic defect
was closed using a 5 3 3-cm polyte-
trafluoroethylene patch with 4-0 Pro-
lene suture. The patient was weaned
uneventfully from cardiopulmonary
bypass. The postoperative course was
uncomplicated. No special treatment
was given except for continuing
intravenous antibiotics for another 4
weeks and oral warfarin. The cause
of the pseudoaneurysm appeared to
Letters to the Editorbe a blowout at the previous aortot-
omy site, because there was no evi-
dence of aortic wall infection
intraoperatively, and histologic exam-
ination and cultures taken from the
pseudoaneurysm remained sterile.
The patient was discharged 4 weeks
later. Heart and prosthetic valve func-
tion were normal, and computed
tomography scan showed no abnor-
mality (Figure 1). We think operation
for ascending aortic pseudoaneurysms
can be safely performed on femorofe-
moral bypass without hypothermic
cardiac arrest.
Jiang Sheng-li, MD
Li Bo-jun, MD
Gao Chang-qing, MD
Department of Cardiovascular
Surgery of Chinese PLA General
Hospital
Chinese PLA Cardiac Surgery
Institute
Beijing, PR China
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CORONARYARTERY BYPASS
GRAFTING: DOES
RHABDOMYOLYSIS PLAY
A ROLE?
To the Editor:
In the August 2010 edition of this
Journal, Periopertive Management
section, the following article was pub-
lished: ‘‘Acute kidney injury after cor-The Journalonary artery bypass grafting: Does
rhabdomyolysis play a role?’’ by Ben-
edetto et al.
The study has hypothesized that
rhabdomyolysis may play a role in
the development of acute kidney in-
jury after coronary artery bypass
grafting. However some important
considerations have been ignored in
the study. (1) The use of depolarizing
muscle relaxant suxamethonium is not
mentioned. Suxamethonium has been
previously shown in literature as a po-
tential cause of muscle injury and
rhabdomyolysis. This is even more
important when given to obese pa-
tients. (2) The use of antifibrinolytic
medications aminocaproic acid (Ami-
car) and tranexamic acid (Cyclokap-
ron) is also not mentioned. Several
case reports have associated rhabdo-
myolysis with their concurrent use in
cardiac surgery. (3) The use of the an-
tiarrhythmic drug amiodarone has not
been addressed. Amiodarone has also
been associated with acute renal in-
jury, especially when used along
with statins. (4) All statins carry
a risk of rhabdomyolysis. However,
the Food and Drug Administration au-
thority has said that the risk of rhabho-
myolysis developing is more
pronounced when simvastatin is com-
bined with amiodarone than it is with
other statin medications. The study
has not provided the different statin
medications the patients were receiv-
ing. (5) The study failed to mention
whether the statin therapy was opti-
mized before the operation. (6) The
anesthetic technique used is totally ig-
nored. Use of several inhalational
agents could potentially increase the
likelihood of renal injury developing,
especially in combination with afore-
mentioned drugs. Was total intrave-
nous anesthesia technique used in
any of the patients in the study? (7)
No information was given about con-
current use of mannitol (especially
during cardiopulmonary bypass).
It is very important to consider all
possible causes of rhabdomyolysis
that can occur during coronary arteryof Thoracic and Cardiovascular Surgebypass grafting. I wish to know from
Benedetto and associates the informa-
tion regarding these questions.
Srikiran Ramarapu
Oklahoma University
Department of Anesthesiology
Oklahoma City, Okla
doi:10.1016/j.jtcvs.2010.09.060Reply to the Editor:
We appreciate the interest in our
work1 and are pleased to address the
aroused considerations.
First, we use cisatracurium, and not
suxamethonium, as a muscle relaxant.
We do not use aminocaproic acid or
tranexamic acid, which is why these
drugs are not mentioned in our article.1
Amiodarone, which is known to play
a role in rhabdomyolysis develop-
ment,2 was entered in themultivariable
correction, but no statistically signifi-
cant correlation was found (P ¼ .75).
Unfortunately, we could not retrieve
information on the different types of
statins that patients were taking be-
cause there were several and it was
a retrospective study; however, we do
know that atorvastatin, simvastatin, ro-
suvastatin, fluvastatin, and pravastatin
were used. Nevertheless, consistent
with the latest guidelines,3 statin ther-
apy was optimized before surgery to
achieve a low-density lipoprotein cho-
lesterol level less than 100 mg/dL, and
this was achieved in 85% of patients.
Anesthetic induction was obtained by
means of sevoflurane, and propofol
was used as maintenance. We believe
these agents do not increase the hazard
of renal impairment. Finally, mannitol
is routinely administered during car-
diopulmonary bypass at a small dose
of 200 to 250 mg.
Emiliano Angeloni, MD
Umberto Benedetto, MD
Riccardo Sinatra, MD
Department of Cardiac Surgery
University of Rome ‘‘La Sapienza’’
Policlinico S. Andrea
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